Novartis CEO Praises Gilead On Remdesivir, Sees Pandemic Silver Linings
Could Defense Budgets Take On Pandemic Plans?
A veteran of the H1N1 pandemic, Narasimhan points out the healthcare failures as well as potential opportunities in COVID-19 pandemic.
You may also be interested in...
Pharma will oppose a patent pool, but the world still needs a way to guarantee fair access to COVID-19 vaccines.
While Moderna and others frontrunners aim for a 2020 emergency use approval, Merck believes a more deliberate approach will pay off in the long term.
Vaccine manufacturing capacity has been lost in the UK in recent decades. Now a new Vaccines Manufacturing Innovation Centre will re-seed that capacity and expertise - and the pandemic is accelerating its arrival.